CION Ameerpet
Practical · Reviewed by CION Oncologists · NABH Accredited
Lynch Syndrome Testing Cost — It Happens in Tiers
Women are frequently quoted the price of full genetic sequencing and conclude that testing for Lynch syndrome is unaffordable. In practice the testing happens in tiers, the first tier is inexpensive and should be done on every endometrial cancer anyway, and most women never need the expensive one. There is a second point worth as much: once a family variant is identified, testing your relatives is far cheaper than the original test was, because only that single variant is examined. This page sets out the steps, what each one answers, and where the cost actually sits.
- Three tiers, not one test — and most women stop at the first
- Tier one should be done anyway — it is part of current staging
- Most MLH1 loss is not inherited — and a cheap test establishes that
- Testing relatives is much cheaper — once the family variant is known
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The Three Tiers
In order. Each step determines whether the next is needed, which is precisely what keeps the cost down.
| Step | What it does and where it sits on cost |
|---|---|
| Tier 1 — mismatch repair immunohistochemistry | Staining the tumour tissue for four proteins. Inexpensive, and it should be done on every endometrial cancer regardless of family history — both for molecular classification, which is part of FIGO 2023 staging, and as a screen for Lynch syndrome. If all four are retained, Lynch syndrome is unlikely and the pathway usually ends here. See MMR and MSI testing. |
| Tier 1 alternative — MSI testing | A molecular test achieving a similar screening purpose where immunohistochemistry is unavailable or equivocal. Comparable role, and centres generally use one or the other. |
| Tier 2 — MLH1 methylation testing | Done only where MLH1 is lost. It distinguishes the common sporadic cause from possible inherited disease. Intermediate cost, and it spares the majority of women with MLH1 loss from proceeding to sequencing. The step most often skipped. |
| Tier 3 — germline sequencing | Sequencing the mismatch repair genes from a blood or saliva sample. Definitive, and the expensive step. Reserved for women in whom the preceding steps indicate it — not a first-line test. See Lynch genetic testing. |
| Afterwards — predictive testing of relatives | Once a family variant is known, relatives are tested for that single variant rather than having whole genes sequenced. Substantially cheaper than the original test, and the highest-value testing in the whole pathway. See testing your family. |
If you have been quoted a large figure, ask which tier it is for. Full germline sequencing quoted to a woman who has not yet had the inexpensive tumour test is the wrong order, and it is a common source of families concluding that testing is out of reach when the first step is not.
Did You Know? The commonest abnormal result on mismatch repair testing is loss of MLH1 — and most of the time it is not inherited at all. The usual cause is a chemical change that switches the gene off within the tumour, acquired during a woman’s life rather than passed down. A specific and relatively inexpensive test distinguishes the two. That single step spares the majority of women with MLH1 loss from expensive germline sequencing, and spares them the anxiety of believing they carry an inherited condition that affects their children. If you have been told there is MLH1 loss and have been quoted for full sequencing, ask whether methylation testing has been done first. Sources: NCCN Clinical Practice Guidelines in Oncology — Genetic/Familial High-Risk Assessment: Colorectal, Endometrial and Gastric; ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma; Manchester International Consensus Group recommendations.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
What the Testing Actually Buys
Five things, and only one of them concerns your own cancer treatment.
- It completes your staging. Mismatch repair status is part of molecular classification, which FIGO 2023 incorporates into staging. A tumour without it has not been fully staged, so tier one is not optional testing in any case.
- It determines systemic treatment options. Mismatch repair status governs eligibility for immune checkpoint inhibition in advanced or recurrent disease. An inexpensive test unlocking an expensive treatment. See immunotherapy cost.
- It changes your own future surveillance. A confirmed Lynch diagnosis means regular colonoscopy, which demonstrably reduces bowel cancer deaths. That is prevention rather than detection. See Lynch surveillance.
- It identifies risk in your relatives. The highest-value outcome. Each first-degree relative has a one in two chance of carrying the same variant, and those who do gain access to surveillance that saves lives. Those who do not can be reassured and discharged.
- It ends uncertainty either way. A negative result in a family worried about inherited cancer is a real outcome with real value, not merely an absence of bad news.
Been Quoted for the Wrong Tier?
Counselling first, then only the testing your situation actually requires.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Ask Which Tier You Are Being Quoted For
Full sequencing before the inexpensive tumour test is the wrong order — and it is common.
Questions Worth Asking
Five that keep the testing appropriate and the cost proportionate.
"Has mismatch repair testing been done on my tumour?"
The first question. It should have been done on every endometrial cancer, and if your report does not mention MLH1, PMS2, MSH2 and MSH6, ask for it — it can nearly always be performed on the stored tissue block and it is inexpensive relative to everything it informs.
"If MLH1 is lost, has methylation testing been done?"
The step most often skipped, and the one that prevents unnecessary expense. Most MLH1 loss is sporadic rather than inherited, and this test establishes that at intermediate cost. Ask before agreeing to germline sequencing.
"Which test exactly is this quote for?"
Tumour immunohistochemistry, methylation testing, a targeted gene panel, or full germline sequencing are very different propositions at very different costs. A quote without a named test is not usable, and it is worth asking for the specific test in writing.
"Is any of this covered?"
Coverage for genetic testing varies considerably between insurers and schemes, and tumour immunohistochemistry is often treated differently from germline testing since it forms part of standard pathology. Ask specifically about each rather than assuming a single answer covers both. See insurance and cover.
"What would testing my relatives cost?"
Ask now rather than later, because it is usually a pleasant surprise. Once a family variant is identified, relatives are tested for that single variant rather than having whole genes sequenced, and it is substantially cheaper. Knowing the figure makes the family conversation easier.
Want to Know Which Test You Actually Need?
Bring your pathology report. Counselling first, then only the tier your situation requires. The opinion is free.
Why Counselling Comes First
It sounds like an added cost and it frequently reduces the total.
- It establishes which test you actually need. A proper family history assessment frequently shows that a cheaper test answers the question, or that no germline testing is indicated at all. That alone can be worth more than the counselling costs.
- It covers what a result would mean before you get one. For you, for your children, and for your siblings. That is worth understanding before the sample is taken rather than after the report arrives.
- It prepares you for an uncertain result. Genetic testing sometimes returns variants of uncertain significance, which are neither reassuring nor actionable. Knowing this is possible in advance prevents a great deal of distress. See genetic counselling.
- It plans the family conversation. How to raise it, whom to approach first, and what to say. Counsellors do this constantly and it is one of the more practically useful things they offer.
- It is the standard of care. Testing preceded by counselling rather than ordered from a price list is how this should be done, and a service that sells sequencing without it is not offering you the whole thing.
Why Tiered Testing Costs Less
Each step decides whether the next is needed. Skipping to the end is both more expensive and less informative.
Lynch counselling built in
MMR / MSI testing as standard
Slides reviewed, not just the summary line
Costs explained before you commit
45-minute consultations
Follow-up you can actually keep
Take The Next Step
Testing Relatives Is the Cheap Part
Once the family variant is known, each relative is tested for that one variant — and it saves lives.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Genetic Testing Cost — Frequently Asked Questions
Why have I been quoted such a high figure?
Almost certainly because you have been quoted for full germline sequencing, which is the most expensive tier and is not where testing starts. The pathway proceeds in steps: immunohistochemistry on the tumour tissue for four mismatch repair proteins is inexpensive and should be done on every endometrial cancer anyway; where MLH1 is lost, methylation testing at intermediate cost distinguishes the common sporadic cause from possible inherited disease; and germline sequencing is reserved for those in whom the earlier steps indicate it. Ask which tier your quote is for, and whether the earlier steps have been done.
What is MLH1 methylation testing and why does it matter?
It is the step that most often prevents unnecessary expense, and it is the one most frequently skipped. Loss of MLH1 is the commonest abnormal result on mismatch repair testing, and most of the time it is not inherited — the usual cause is a chemical change that switches the gene off within the tumour itself, acquired during life rather than passed down. Methylation testing distinguishes the two at intermediate cost. Where it shows the sporadic pattern, expensive germline sequencing is generally unnecessary, and you are spared both the cost and the anxiety of believing you carry an inherited condition.
Should I have testing if I have no family history?
Yes, for the first tier at least — and it is not really a choice, since mismatch repair testing on the tumour is part of molecular classification, which FIGO 2023 incorporates into staging. Family history is a poor filter here: a meaningful proportion of women found to have Lynch syndrome have no striking family history, because families are small, relatives are unaware of their diagnoses, or the variant came through a line with few affected women. That is precisely why current practice tests all endometrial cancers rather than testing selectively on family history.
What does it cost to test my relatives?
Substantially less than your own testing did, which is usually a welcome surprise. Once a specific pathogenic variant has been identified in your family, relatives are tested only for that single variant rather than having whole genes sequenced — a much simpler and cheaper test. This matters because each first-degree relative has a one in two chance of carrying it, those who do can enter surveillance that demonstrably reduces bowel cancer deaths, and those who do not can be reassured and discharged. It is the highest-value testing in the entire pathway.
Is genetic testing covered by insurance?
It varies considerably, and the two ends of the pathway are often treated differently. Mismatch repair immunohistochemistry on the tumour is generally handled as part of standard pathology, since it forms part of staging, whereas germline genetic testing may be treated separately by insurers and by state schemes. Ask specifically about each rather than assuming one answer covers both, and ask before testing is ordered rather than afterwards. Where cost is a genuine obstacle, say so — the tiered approach frequently means the question can be answered adequately without reaching the expensive step.
Medical disclaimer: This page explains how testing for Lynch syndrome is structured and how costs arise at each step. It is reviewed by a CION oncologist and deliberately does not publish price figures, because costs vary with the specific test, the laboratory and funding arrangements. Genetic testing should be preceded by genetic counselling, and decisions about which tests are appropriate should be made with a clinical genetics service.